ATP5IF1 and breast carcinoma: In contrast, the overexpression of IF1 in colon and breast carcinomas correlates with better patients’ prognosis16,53, stressing the importance and tissue-specific relevance of IF1 as a biomarker and target of cancer chemotherapy.